Broecker, Felix
Liu, Sean T. H.
Suntronwong, Nungruthai http://orcid.org/0000-0002-0714-6470
Sun, Weina
Bailey, Mark J.
Nachbagauer, Raffael http://orcid.org/0000-0001-5568-5420
Krammer, Florian
Palese, Peter
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (HHSN272201400008C, P01 AI097092, U19 AI109946, HHSN272201400008C, P01 AI097092, U19 AI109946, HHSN272201400008C, P01 AI097092, U19 AI109946, HHSN272201400008C, P01 AI097092, U19 AI109946, HHSN272201400008C, P01 AI097092, U19 AI109946, HHSN272201400008C, P01 AI097092, U19 AI109946, HHSN272201400008C, P01 AI097092, U19 AI109946)
Division of Intramural Research, National Institute of Allergy and Infectious Diseases (HHSN272201400008C, U19 AI109946)
Article History
Received: 8 April 2019
Accepted: 27 June 2019
First Online: 19 July 2019
Competing interests
: The Icahn School of Medicine at Mount Sinai has filed patent applications regarding influenza virus vaccines that name F.B., F.K., and P.P. as inventors. The laboratories of F.K. and P.P. have received funding for a research program from GlaxoSmithKline. The other authors declare no competing interests.